Does ALPRAZOLAM Cause Incorrect product administration duration? 72 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Incorrect product administration duration have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.2% of all adverse event reports for ALPRAZOLAM.
72
Reports of Incorrect product administration duration with ALPRAZOLAM
0.2%
of all ALPRAZOLAM reports
0
Deaths
18
Hospitalizations
How Dangerous Is Incorrect product administration duration From ALPRAZOLAM?
Of the 72 reports, 18 (25.0%) required hospitalization, and 9 (12.5%) were considered life-threatening.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which ALPRAZOLAM Alternatives Have Lower Incorrect product administration duration Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE